Maxigen Biotech Inc. | Income Statement
Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
232,947.00
245,686.00
261,469.00
336,388.00
427,561.00
427,680
Cost of Goods Sold (COGS) incl. D&A
129,306.00
153,160.00
177,874.00
213,510.00
280,037.00
254,792
Gross Income
103,641.00
92,526.00
83,595.00
122,878.00
147,524.00
172,888
SG&A Expense
107,200.00
118,872.00
144,119.00
132,619.00
126,476.00
126,700
EBIT
3,559.00
26,346.00
60,524.00
9,741.00
21,048.00
46,188
Unusual Expense
1,679.00
93.00
5,927.00
4,305.00
4,065.00
-
Non Operating Income/Expense
1,304.00
2,140.00
2,133.00
4,039.00
5,786.00
11,665
Interest Expense
1,683.00
1,636.00
2,263.00
4,814.00
4,117.00
4,016
Pretax Income
3,415.00
18,897.00
62,063.00
11,959.00
16,695.00
57,308
Income Tax
831.00
144.00
896.00
288.00
908.00
253
Consolidated Net Income
2,584.00
19,041.00
62,959.00
12,247.00
15,787.00
57,055
Net Income
2,584.00
19,041.00
62,959.00
12,247.00
15,787.00
57,055
Net Income After Extraordinaries
2,584.00
19,041.00
62,959.00
12,247.00
15,787.00
57,055
Net Income Available to Common
2,584.00
19,041.00
62,959.00
12,247.00
15,787.00
57,055
EPS (Basic)
0.04
0.27
0.89
0.18
0.23
0.82
Basic Shares Outstanding
60,219.00
70,130.00
70,704.00
69,778.00
69,465.00
69,465
EPS (Diluted)
0.04
0.27
0.89
0.18
0.23
0.78
Diluted Shares Outstanding
60,893.00
70,130.00
70,704.00
69,778.00
69,518.00
77,564
EBITDA
3,061.00
19,628.00
48,332.00
8,344.00
46,785.00
72,403
Non-Operating Interest Income
3,310.00
5,717.00
3,073.00
2,330.00
1,485.00
3,471
About Maxigen Biotech
View Profile
